We Listen Therapies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.45 M
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About We Listen Therapies
We Listen Therapies Private Limited (WLTPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 July 1999 and has a history of 25 years and six months. Its registered office is in New Delhi, India.
The Corporate was formerly known as Karuna Technologies Pvt Ltd. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.45 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Dugar and Siddhi Dugar serve as directors at the Company.
Company Details
-
Location
New Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72900DL1999PTC100529
-
Company No.
100529
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jul 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at We Listen Therapies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Dugar
|
Director | 25-Jul-1999 | Current |
|
Siddhi Dugar
|
Director | 20-Aug-2021 | Current |
Financial Performance of We Listen Therapies.
We Listen Therapies Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of We Listen Therapies?
In 2017, We Listen Therapies had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Supriya Pharmaceuticals LimitedRamesh Dugar is a mutual person
-
Dakesh Builders Pvt Ltd
Ramesh Dugar is a mutual person
-
Tarini Overseas Private Limited
Ramesh Dugar is a mutual person
-
R Net Intelligence Systems Private Limited
Ramesh Dugar and Siddhi Dugar are mutual person
-
Samriddhi Mega Structures Limited
Ramesh Dugar is a mutual person
-
Trancelogics Private Limited
Ramesh Dugar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at We Listen Therapies?
Unlock and access historical data on people associated with We Listen Therapies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of We Listen Therapies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped We Listen Therapies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
